coronavirus Archives
Study finds patients defer routine health care during pandemic
Jul. 29, 2020—During February and March at two large academic medical centers in Nashville and Boston, screening for high cholesterol and high blood sugar dropped 81-90% and initiation of drug therapy for these conditions dropped 52-60%.
Health, well-being and food security of families deteriorating under COVID-19 stress
Jul. 24, 2020—The ongoing disruptive changes from efforts to reduce the spread of COVID-19 are having a substantial negative impact on the physical and mental well-being of parents and their children across the country, according to a new national survey published today in Pediatrics.
Study to explore how COVID affects cognition over time
Jul. 22, 2020—The Critical Illness, Brain Dysfunction and Survivorship Center at Vanderbilt University Medical Center is following patients who have been hospitalized for COVID-19 over time to see if they develop long-term cognitive impairment, depression or post-traumatic stress disorder (PTSD).
New data offer insights on COVID treatments for people with cancer
Jul. 22, 2020—Newly released data on treatment outcomes of people with cancer diagnosed with COVID-19 reveal a racial disparity in access to Remdesivir, an antiviral drug that has been shown to shorten hospital stays, and increased mortality associated with dexamethasone, a steroid that has had the opposite effect in the general patient population.
Button Project lets children see the faces behind the masks
Jul. 16, 2020—Children and their families who come to Monroe Carell Jr. Children’s Hospital at Vanderbilt for their care are used to seeing the friendly faces and smiles of staff, nurses and doctors.
Investigational glaucoma drug studied to prevent respiratory distress in COVID-19 patients
Jul. 16, 2020—Vanderbilt University Medical Center is evaluating razuprotafib, a drug being investigated for the treatment of glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.
Antibody research at Vanderbilt University Medical Center shows promise in fight against COVID-19
Jul. 15, 2020—Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19.
Vanderbilt University Medical Center to recruit up to 1,000 volunteers for COVID-19 vaccine Trial
Jul. 15, 2020—In late July, Vanderbilt University Medical Center will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.
VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial
Jul. 14, 2020—An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.
VUMC team fills COVID information gaps for web users
Jul. 10, 2020—For the world’s web users, Vanderbilt University Medical Center is working with Google to address COVID-19 information gaps.
About half of health care workers positive for COVID-19 by serology have no symptoms
Jul. 9, 2020—The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients.
New study supports remdesivir as COVID-19 treatment
Jul. 9, 2020—This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported that remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19, in human lung cell cultures and that it improved lung function in mice infected with the virus.
